BioWorld MedTech
Archive Search

User ID

Password

Forgot password

Remember my login



New User ?

BioWorld MedTech Twitter

Clarivate Analytics

Today's Issue of BioWorld MedTech

Wednesday, August 23, 2017

Today's Headlines

Cerene menstrual device-maker Channel nets $14.1M in series C-1 for clinic trials

Channel Medsystems closed a series C-1 financing of $14.1 million led by insider investors. The company has developed a the Cerene physician-office cryotherapy device for heavy menstrual bleeding. Funds will be applied to efforts to seek FDA approval of the device, and for commercialization at a later date.

Columbia researchers reveal novel technique to link 'dark genome' to genetic diseases

Elucidating the role of genetics in understanding disease is a driving force for the diagnostic and biopharmaceutical industries. But, until now, much of the human genome has remained largely a mystery. Scientists have long focused on the portion that codes for proteins – but that represents only 2 percent of the human genome. Researchers at Columbia University Medical Center have developed a new technique, known as Orion, which interrogates the noncoding 98 percent, the so-called 'dark genome.'

Vascular Dynamics receives approval for pivotal trial to treat resistant hypertension

Vascular Dynamics Inc. (VDI), a private company, said the FDA has approved an IDE application to initiate a pivotal trial for the Mobiushd system in the treatment of resistant hypertension. The Controlling and Lowering Blood Pressure with Mobiushd (CALM) 2 trial is a multicenter, prospective, randomized, double-blind, sham-controlled pivotal study.


Home   |   About Us   |   Contact Us   |   Copyright Notices   |   Terms of Use   |   Privacy Statement

clarivate.com | BioWorld.com | bioworldmedtech.com